D-0484-2026 Class II Ongoing
FDA drug recall D-0484-2026 was initiated by Hetero Labs Limited (Unit V) on Mar 26, 2026 and is designated Class II. Reason for recall: Discoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than normal and have lighter-colored spots." The recall status is ongoing. Affected quantity: 4,740 1,000-count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 29, 2026
- Initiation Date
- Mar 26, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4,740 1,000-count bottles.
Product description
Pantoprazole Sodium, Delayed-Release Tablets, USP, 40 mg, 1000-count bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, By: Hetero, Hetero Labs Limited, Unit V, Polepally, Jadcherta, Mahabubager-509 301, India, NDC 31722-713-10
Reason for recall
Discoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than normal and have lighter-colored spots."
Distribution pattern
Nationwide in the USA.
Code information
Batch # FD253967, Exp Date: 06/26/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0484-2026
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026